NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE2206.30-35.65 (-1.59 %)
PREV CLOSE ( ) 2241.95
OPEN PRICE ( ) 2235.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4154
TODAY'S LOW / HIGH ( )2168.80 2235.40
52 WK LOW / HIGH ( )1880.1 2766.85
NSE2209.20-35.4 (-1.58 %)
PREV CLOSE( ) 2244.60
OPEN PRICE ( ) 2235.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2209.20 (194)
VOLUME 245714
TODAY'S LOW / HIGH( ) 2165.80 2237.75
52 WK LOW / HIGH ( )1880.1 2767.1
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 14-02 1995
Management Info
Arvind Lal - Chairman Om Prakash Manchanda - Managing Director
Registered Office

Address Block E,Sector 18,Rohini,
New Delhi,
Delhi-110085

Phone 011-49885050

Email cs@lalpathlabs.com

Website www.lalpathlabs.com

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
 Listing : BSE, NSE
NEWS
26Mar Dr. Lal PathLabs informs about closure
Dr. Lal PathLabs has informed that as per the provisions of the SEBI (Pr..
18Mar Dr. Lal PathLabs informs about outcome
Dr. Lal PathLabs has informed that, based on recommendations of Nominati..
18Mar Board Meeting Outcome for Appointment
Based on recommendations of Nomination & Remuneration Committee, the Boa..
01Feb Dr. Lal PathLabs informs about earning
Dr. Lal PathLabs has informed that it attached a copy of Company's Q3 &a..
25Jan Dr. Lal PathLabs informs about closure
Dr. Lal PathLabs has informed that a meeting of the Board of Directors i..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit8832924
Gross Profit 1195 3908
Operating Profit 14525073
Net Sales 476017690
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Apollo Hospital Ent. (BSE)
 6170.05 (1.68%)
M.Cap (Rs. in Cr)88715.85
Global Health (BSE)
 1402.45 (2.25%)
M.Cap (Rs. in Cr)37656.82
Dr Agarwals Eye Hsp (BSE)
 3282.00 (0.94%)
M.Cap (Rs. in Cr)1542.54
Thyrocare Tech. (BSE)
 634.85 (2.99%)
M.Cap (Rs. in Cr)3361.70
Yatharth Hospital (BSE)
 460.10 (2.39%)
M.Cap (Rs. in Cr)3949.97
MORE
Shareholding Pattern
PROMOTERS 54.6%
NON-INSTITUTION 9.56%
MUTUAL FUNDS/UTI 6.79%
FI/BANKS/INSURANCE 2.3%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.